RedHill Biopharma Ltd. (RDHL) stock
RDHLNasdaqPharmaceutical Preparations
$0.35−0.01 (-2.91%)
Close on Nov 17, 2026Market cap $1.78MP/E –Yield –
RedHill Biopharma total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
RedHill Biopharma's total debt was $115.22M at Dec 31, 2022. For fiscal 2022 it was $115.22M, up 37.8% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $115.22M | +37.8% |
| FY2021 | Dec 31, 2021 | $83.62M | +2.7% |
| FY2020 | Dec 31, 2020 | $81.39M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $115.22M | +41.6% |
| Q2 FY2022 | Jun 30, 2022 | $85.51M | +8.0% |
| Q4 FY2021 | Dec 31, 2021 | $83.62M | – |
| Q2 FY2021 | Jun 30, 2021 | $83.16M | – |
| Q4 FY2020 | Dec 31, 2020 | $81.39M | – |
| Q2 FY2020 | Jun 30, 2020 | $79.19M | – |
See a number that looks wrong?